Helsinki, Finland

Osmo A Suovaniemi

This inventor holds 37 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Liquid Handling Technologies. Top assignees: Biohit Oyj, Kommandiittiyhtio Finnpipette Osmo a. Suovaniemi, Labsystems Oy. Active years: 1979-2018.

USPTO Granted Patents = 37 

% Patents Active = 94.6

 

 

Average Co-Inventor Count = 1.9

ph-index = 13

Forward Citations = 544(Granted Patents)


Location History:

  • 00570 Helsinki 57, FI (1979)
  • 00570 Helsinki, FI (1980)
  • SF-00580 Helsinki, FI (1996)
  • Helsinki, FI (1979 - 2018)

Company Filing History:


Years Active: 1979-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pipette
Suction Device
Immunoassay
Liquid Dispensing
Cuvette
Photometer
Microvette Assembly
Transfer Device
Liquid Portioning
Dosage
Agglutination Tests
Chemical Measurement
37 patents (USPTO):Explore Patents

Title: Osmo A Suovaniemi: A Innovator Paving the Way for Medical Breakthroughs

Introduction:

Osmo A Suovaniemi, a prolific innovator hailing from Helsinki, FI, has made tremendous contributions to the field of innovation throughout his illustrious career. With a remarkable track record of 34 patents, Suovaniemi's work has focused on pioneering advancements in the medical sector. This article delves into his latest patents, career highlights, notable collaborations, and the profound impact he has made within the field of innovation.

Latest Patents:

One of Suovaniemi's most recent patents is titled "Composition for Treating Headaches." This invention revolves around a non-toxic solid pharmaceutical composition for oral administration. The composition is comprised of cysteine compounds (L-cysteine, D-cysteine, and N-acetyl cysteine) combined with additional active agents, including cystine, glutathione, and methionine. Designed to reduce the incidence of severe headaches, particularly migraine and/or cluster headaches, this patent showcases Suovaniemi's dedication to addressing common medical ailments.

Another notable patent by Suovaniemi is "Methods and Products for Diagnosing Autoimmune Disease and Gastric Cancer Linked with Atrophic Gastritis." This invention presents a method for diagnosing atrophic gastritis in individuals showing symptoms and/or biomarkers indicating an autoimmune disease. Additionally, the biomarker combination identified in this patent aids in diagnosing and assessing autoimmune diseases. Suovaniemi's innovative approach to diagnosis provides significant advancements within the medical field.

Career Highlights:

Throughout his career, Suovaniemi has garnered recognition for his exceptional work as an innovator. Having accumulated a staggering 34 patents, his dedication and expertise have paved the way for groundbreaking advancements. He has consistently demonstrated an ability to identify and address unmet medical needs, resulting in innovative solutions that improve patient outcomes. Suovaniemi's commitment to innovative research and development has earned him a notable reputation within the medical community.

Collaborations:

Suovaniemi's ability to collaborate with industry experts has further augments his contributions to innovation. Notably, he has worked with esteemed companies such as Biohit Oyj and Kommandiittiyhtio Finnpipette Osmo A. Suovaniemi. These collaborations have allowed him to leverage the expertise of his peers and develop groundbreaking solutions. Among Suovaniemi's notable coworkers are Pertti Ekholm and Esko Kaukanen, both of whom have contributed significantly to the field of innovation.

Conclusion:

Osmo A Suovaniemi's remarkable career as an innovator has revolutionized the medical field. With a vast portfolio of 34 patents, his inventions have addressed critical medical challenges, ranging from headache treatment to autoimmune disease diagnosis. Collaborating with renowned companies and esteemed colleagues, Suovaniemi continues to drive advancements in the healthcare industry. Through his pioneering spirit and dedication to improving patient well-being, Suovaniemi's contributions to innovation leave a lasting impact on the medical community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…